Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial
Year: 2018
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Respiratory Medicine
Institutions: Medical University of Vienna, General University Hospital in Prague, Jagiellonian University, John Paul II Hospital, University Hospital Carl Gustav Carus, Technische Universität Dresden, Slovak Medical University, National Institute of Cardiovascular Diseases, Semmelweis University, Krankenhaus der Elisabethinen, University Hospital Centre Zagreb, Ljubljana University Medical Centre
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Austrian Science Fund
OpenAlex ID: W2901188823
